Zimmerman program on the biology of VWD

Ended Project Grant Awarded Last action

Award ID
P01HL144457
Recipient
Awarding agency
Obligated
$13,270,012

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date
Originally
Place of performance
Wauwatosa, WI 53226, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment -$25,135
Amendment $2,629,473
Amendment $263,047
Amendment $2,367,393
Amendment $2,638,519
Amendment $2,661,927
Amendment $0
Amendment $32,853
Original award $2,701,935

Subawards

Subrecipient Amount Awarded
Royal College Of Surgeons In Ireland The program of work to be carried out in Dublin will first investigate the glycan structures expressed on plasma VWF in patients with low VWF levels using a… $210,600
The Washington University Core B, led by Drs. Di Paola and Sadler, will provide DNA and RNA sequencing, as well as epigenetics studies for all projects of this Program Project Grant… $467,512
Queens University At Kingston The overall aim of Project 3 is to evaluate the influence of genetic variants outside of the VWF gene as contributors to inherited quantitative pathologies… $214,920
University Of Colorado At Denver Von Willebrand factor (VWF) is an essential hemostatic protein and alterations of VWF levels are associated with bleeding and thrombosis. VWF levels < 50… $388,750

Quick answers

Who received award P01HL144457?

P01HL144457 was awarded to Versiti Blood Health, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on March 11, 2019.

How much is award P01HL144457 worth?

$13,270,012 has been obligated on P01HL144457.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login